Cardiol Therapeutics Inc. (CRDL)

NASDAQ: CRDL · Real-Time Price · USD

1.200

-0.100 (-7.69%)

At close: Feb 21, 2025, 4:00 PM

1.260

+0.060 (5.00%)

After-hours: Feb 21, 2025, 4:13 PM EST

Cardiol Therapeutics Employees

Cardiol Therapeutics had 6 employees as of December 31, 2018.

Employees

6

Change

n/a

Growth

n/a

Revenue / Employee

n/a

Profits / Employee

-$4,458,098

Market Cap

99.38M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2018	6	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	440,000
Johnson & Johnson	131,900
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	72,000

Employee Rankings

CRDL News

2 days ago - Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure - Newsfile Corp
3 days ago - Cardiol Therapeutics: Bargain Stock Price With Share Price Appreciation Catalysts - Seeking Alpha
18 days ago - Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - Newsfile Corp
2 months ago - PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis - GlobeNewsWire
3 months ago - Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024 - Newsfile Corp
3 months ago - Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index - GlobeNewsWire
4 months ago - Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis - Newsfile Corp
4 months ago - Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option - Newsfile Corp